These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 33280512)

  • 1. Challenges in Treating
    Singh D; Johnson M; Kitchens CS; Boone A
    J Pharm Pract; 2022 Jun; 35(3):492-494. PubMed ID: 33280512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
    J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?
    Hanson KE; Slechta ES; Muir H; Barker AP
    J Clin Microbiol; 2014 May; 52(5):1705-7. PubMed ID: 24554745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report.
    Akiyama Y; Iwamoto N; Kamada K; Yoshida A; Osugi A; Mitarai S; Suzuki T; Yamamoto K; Nagashima M; Horai T; Ohmagari N
    BMC Infect Dis; 2023 Oct; 23(1):694. PubMed ID: 37848843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Inducible Macrolide Resistance in Mycobacterium chelonae Due to Broad-Host-Range Plasmid and Chromosomal Variants of the Novel 23S rRNA Methylase Gene,
    Brown-Elliott BA; Wallace RJ; Wengenack NL; Workman SD; Cameron ADS; Bush G; Hughes MD; Melton S; Gonzalez-Ramirez B; Rodriguez E; Somayaji K; Klapperich C; Viers M; Bolaji AJ; Rempel E; Alexander DC
    J Clin Microbiol; 2023 Jul; 61(7):e0042823. PubMed ID: 37347171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
    Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
    J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.
    Kumar C; Shrivastava K; Singh A; Chauhan V; Varma-Basil M
    Int J Mycobacteriol; 2021; 10(3):293-300. PubMed ID: 34494569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.
    Brown-Elliott BA; Hanson K; Vasireddy S; Iakhiaeva E; Nash KA; Vasireddy R; Parodi N; Smith T; Gee M; Strong A; Barker A; Cohen S; Muir H; Slechta ES; Wallace RJ
    J Clin Microbiol; 2015 Mar; 53(3):875-8. PubMed ID: 25568437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P; Sultan F; Wallace RJ; Fraser V
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid Mycobacterium abscessus antimicrobial susceptibility testing based on antibiotic treatment response mapping via Raman Microspectroscopy.
    Ren W; Mao Y; Li S; Gao B; Fu X; Liu X; Zhu P; Shang Y; Li Y; Ma B; Sun L; Xu J; Pang Y
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):94. PubMed ID: 37904155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
    Nash KA; Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1367-76. PubMed ID: 19171799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species.
    Watanabe J; Ihara H; Takei S; Nakamura A; Fujimoto Y; Handoh T; Kurokawa K; Arai Y; Shibayama K; Sumiyoshi I; Ochi Y; Okabe T; Misawa S; Togo S; Naito T; Tabe Y; Miida T; Takahashi K
    Sci Rep; 2023 Feb; 13(1):2027. PubMed ID: 36739345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
    Petrini B
    APMIS; 2006 May; 114(5):319-28. PubMed ID: 16725007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.